Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein phosphatase binding	PPP2CA JUP CTNND1 PPP1R9A INSR	4.07e-05	210	37	5	GO:0019903
GeneOntologyMolecularFunction	phosphatase binding	PPP2CA JUP CTNND1 PPP1R9A INSR	1.20e-04	264	37	5	GO:0019902
GeneOntologyMolecularFunction	dipeptidyl-peptidase activity	DPP4 DPP9	2.18e-04	12	37	2	GO:0008239
GeneOntologyMolecularFunction	transmembrane transporter binding	PPP2CA PPP2CB FLNA PPP1R9A	2.81e-04	172	37	4	GO:0044325
GeneOntologyMolecularFunction	kinase binding	PPP2CA FLNA JUP CACNB3 CTNND1 MYOM1 PPP1R9A INSR	3.28e-04	969	37	8	GO:0019900
GeneOntologyMolecularFunction	protein kinase binding	PPP2CA FLNA JUP CACNB3 CTNND1 PPP1R9A INSR	9.72e-04	873	37	7	GO:0019901
GeneOntologyMolecularFunction	protein domain specific binding	PPP2CA CTNND1 LAT2 EFS INPP5A PPP1R9A INSR	9.85e-04	875	37	7	GO:0019904
GeneOntologyMolecularFunction	exopeptidase activity	DPP4 DPP9 AEBP1	1.10e-03	110	37	3	GO:0008238
GeneOntologyMolecularFunction	phosphatase activity	PPP2CA PPP2CB SBF1 INPP5A	1.90e-03	287	37	4	GO:0016791
GeneOntologyMolecularFunction	aminopeptidase activity	DPP4 DPP9	2.88e-03	43	37	2	GO:0004177
GeneOntologyMolecularFunction	tau protein binding	PPP2CA PPP2CB	3.28e-03	46	37	2	GO:0048156
GeneOntologyMolecularFunction	ion channel regulator activity	FLNA CACNB3 WNK2	3.33e-03	162	37	3	GO:0099106
GeneOntologyMolecularFunction	iron ion binding	JMJD6 HEPH ALOX15B	3.56e-03	166	37	3	GO:0005506
GeneOntologyMolecularFunction	channel regulator activity	FLNA CACNB3 WNK2	4.07e-03	174	37	3	GO:0016247
GeneOntologyMolecularFunction	transporter regulator activity	FLNA CACNB3 WNK2	4.26e-03	177	37	3	GO:0141108
GeneOntologyMolecularFunction	potassium channel regulator activity	FLNA WNK2	5.00e-03	57	37	2	GO:0015459
GeneOntologyMolecularFunction	phosphoprotein phosphatase activity	PPP2CA PPP2CB SBF1	5.12e-03	189	37	3	GO:0004721
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	PPP2CA PPP2CB SBF1 INPP5A	5.49e-03	386	37	4	GO:0042578
GeneOntologyCellularComponent	zonula adherens	JUP CTNND1	8.48e-05	8	37	2	GO:0005915
GeneOntologyCellularComponent	focal adhesion	LRP1 DPP4 FLNA JUP EFS ALOX15B	1.00e-04	431	37	6	GO:0005925
GeneOntologyCellularComponent	cell-substrate junction	LRP1 DPP4 FLNA JUP EFS ALOX15B	1.17e-04	443	37	6	GO:0030055
GeneOntologyCellularComponent	FAR/SIN/STRIPAK complex	PPP2CA PPP2CB	4.08e-04	17	37	2	GO:0090443
GeneOntologyCellularComponent	membrane raft	PPP2CA DPP4 CTNND1 LAT2 INSR	4.19e-04	362	37	5	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	PPP2CA DPP4 CTNND1 LAT2 INSR	4.29e-04	364	37	5	GO:0098857
GeneOntologyCellularComponent	protein phosphatase type 2A complex	PPP2CA PPP2CB	4.58e-04	18	37	2	GO:0000159
GeneOntologyCellularComponent	dendrite	LRP1 FLNA CTNND1 KIF1A INPP5A PPP1R9A INSR	6.71e-04	858	37	7	GO:0030425
GeneOntologyCellularComponent	dendritic tree	LRP1 FLNA CTNND1 KIF1A INPP5A PPP1R9A INSR	6.80e-04	860	37	7	GO:0097447
GeneOntologyCellularComponent	axon	LRP1 PPP2CA FLNA CTNND1 KIF1A PPP1R9A INSR	8.38e-04	891	37	7	GO:0030424
GeneOntologyCellularComponent	growth cone	LRP1 FLNA CTNND1 PPP1R9A	8.97e-04	245	37	4	GO:0030426
GeneOntologyCellularComponent	distal axon	LRP1 PPP2CA FLNA CTNND1 PPP1R9A	9.60e-04	435	37	5	GO:0150034
GeneOntologyCellularComponent	site of polarized growth	LRP1 FLNA CTNND1 PPP1R9A	1.01e-03	253	37	4	GO:0030427
GeneOntologyCellularComponent	apicolateral plasma membrane	JUP CTNND1	1.12e-03	28	37	2	GO:0016327
GeneOntologyCellularComponent	anchoring junction	LRP1 DPP4 FLNA JUP CTNND1 EFS ALOX15B	1.43e-03	976	37	7	GO:0070161
GeneOntologyCellularComponent	catenin complex	JUP CTNND1	1.46e-03	32	37	2	GO:0016342
GeneOntologyCellularComponent	cell leading edge	DPP4 CTNND1 DPP9 PPP1R9A INSR	1.78e-03	500	37	5	GO:0031252
GeneOntologyCellularComponent	plasma membrane protein complex	LRP1 FLNA JUP CACNB3 CTNND1 INSR	2.36e-03	785	37	6	GO:0098797
GeneOntologyCellularComponent	axonal growth cone	LRP1 FLNA	2.88e-03	45	37	2	GO:0044295
GeneOntologyCellularComponent	cell-cell junction	DPP4 FLNA JUP CTNND1 ALOX15B	3.66e-03	591	37	5	GO:0005911
GeneOntologyCellularComponent	phosphatase complex	PPP2CA PPP2CB	4.27e-03	55	37	2	GO:1903293
GeneOntologyCellularComponent	protein serine/threonine phosphatase complex	PPP2CA PPP2CB	4.27e-03	55	37	2	GO:0008287
GeneOntologyCellularComponent	somatodendritic compartment	LRP1 FLNA CTNND1 KIF1A INPP5A PPP1R9A INSR	5.17e-03	1228	37	7	GO:0036477
GeneOntologyCellularComponent	spindle pole	TUBGCP6 PPP2CA PPP2CB	5.65e-03	205	37	3	GO:0000922
GeneOntologyCellularComponent	adherens junction	JUP CTNND1 ALOX15B	6.20e-03	212	37	3	GO:0005912
HumanPheno	Osteolysis involving bones of the lower limbs	FLNA KIF1A NOTCH2	7.14e-06	13	16	3	HP:0009139
HumanPheno	Osteolytic defects of the hand bones	FLNA KIF1A NOTCH2	2.81e-05	20	16	3	HP:0009699
HumanPheno	Osteolytic defects of the phalanges of the hand	FLNA KIF1A NOTCH2	2.81e-05	20	16	3	HP:0009771
HumanPheno	Osteolytic defects of bones	FLNA KIF1A NOTCH2	4.33e-05	23	16	3	HP:0010737
HumanPheno	Osteolysis involving bones of the upper limbs	FLNA KIF1A NOTCH2	4.33e-05	23	16	3	HP:0045039
HumanPheno	Nail dysplasia	FLNA JUP CTNND1 KIF1A NOTCH2 INSR	9.44e-05	264	16	6	HP:0002164
HumanPheno	Osteolytic defects of the phalanges of the toes	KIF1A NOTCH2	2.56e-04	8	16	2	HP:0010177
HumanPheno	Absent frontal sinuses	FLNA NOTCH2	2.56e-04	8	16	2	HP:0002688
HumanPheno	Foot acroosteolysis	KIF1A NOTCH2	2.56e-04	8	16	2	HP:0001842
HumanPheno	Abnormal sella turcica morphology	FLNA AEBP1 NOTCH2	2.71e-04	42	16	3	HP:0002679
Domain	Arm	JUP CTNND1 ANKAR	3.36e-05	31	38	3	PF00514
Domain	-	DPP4 DPP9	6.02e-05	6	38	2	2.140.10.30
Domain	DPPIV_N	DPP4 DPP9	6.02e-05	6	38	2	PF00930
Domain	Peptidase_S9B_N	DPP4 DPP9	6.02e-05	6	38	2	IPR002469
Domain	ARM_REPEAT	JUP CTNND1 ANKAR	7.29e-05	40	38	3	PS50176
Domain	ARM	JUP CTNND1 ANKAR	7.29e-05	40	38	3	SM00185
Domain	Armadillo	JUP CTNND1 ANKAR	1.18e-04	47	38	3	IPR000225
Domain	Peptidase_S9	DPP4 DPP9	2.19e-04	11	38	2	PF00326
Domain	Peptidase_S9	DPP4 DPP9	2.19e-04	11	38	2	IPR001375
Domain	Growth_fac_rcpt_	LRP1 CELSR1 NOTCH2 INSR	2.77e-04	156	38	4	IPR009030
Domain	Ser/Thr-sp_prot-phosphatase	PPP2CA PPP2CB	3.10e-04	13	38	2	IPR006186
Domain	SER_THR_PHOSPHATASE	PPP2CA PPP2CB	3.10e-04	13	38	2	PS00125
Domain	PP2Ac	PPP2CA PPP2CB	3.10e-04	13	38	2	SM00156
Domain	ASX_HYDROXYL	LRP1 CELSR1 NOTCH2	1.10e-03	100	38	3	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	LRP1 CELSR1 NOTCH2	1.30e-03	106	38	3	IPR000152
Domain	Calcineurin-like_PHP_ApaH	PPP2CA PPP2CB	1.47e-03	28	38	2	IPR004843
Domain	Metallophos	PPP2CA PPP2CB	1.47e-03	28	38	2	PF00149
Domain	Metallo-depent_PP-like	PPP2CA PPP2CB	1.69e-03	30	38	2	IPR029052
Domain	-	PPP2CA PPP2CB	1.69e-03	30	38	2	3.60.21.10
Domain	EGF_CA	LRP1 CELSR1 NOTCH2	1.94e-03	122	38	3	SM00179
Domain	EGF-like_Ca-bd_dom	LRP1 CELSR1 NOTCH2	2.03e-03	124	38	3	IPR001881
Domain	EGF	LRP1 CELSR1 NOTCH2	2.13e-03	126	38	3	PF00008
Domain	-	JUP CTNND1 ANKAR	1.03e-02	222	38	3	1.25.10.10
Domain	EGF_3	LRP1 CELSR1 NOTCH2	1.20e-02	235	38	3	PS50026
Domain	EGF	LRP1 CELSR1 NOTCH2	1.20e-02	235	38	3	SM00181
Pathway	REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PPP2CA PPP2CB	1.11e-04	7	33	2	M26992
Pathway	REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION	JUP CTNND1	1.11e-04	7	33	2	M48017
Pathway	REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS	JUP CTNND1	1.11e-04	7	33	2	M48038
Pathway	REACTOME_REGULATION_OF_CDH11_FUNCTION	JUP CTNND1	1.47e-04	8	33	2	MM17072
Pathway	REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION	PPP2CA PPP2CB	2.36e-04	10	33	2	M27176
Pathway	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	PPP2CA PPP2CB	2.36e-04	10	33	2	MM14509
Pathway	REACTOME_REGULATION_OF_CDH11_FUNCTION	JUP CTNND1	2.88e-04	11	33	2	M48015
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PPP2CA PPP2CB	3.46e-04	12	33	2	M27950
Pathway	REACTOME_REGULATION_OF_CDH11_EXPRESSION_AND_FUNCTION	JUP CTNND1	3.46e-04	12	33	2	MM17071
Pathway	REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1	PPP2CA PPP2CB	4.08e-04	13	33	2	M1015
Pathway	REACTOME_ERKS_ARE_INACTIVATED	PPP2CA PPP2CB	4.08e-04	13	33	2	MM14811
Pathway	WP_DOPAMINE_METABOLISM	PPP2CA PPP2CB	4.08e-04	13	33	2	M39622
Pathway	REACTOME_ERKS_ARE_INACTIVATED	PPP2CA PPP2CB	4.08e-04	13	33	2	M8410
Pathway	REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS	PPP2CA PPP2CB	5.47e-04	15	33	2	M27407
Pathway	KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE	PPP2CA PPP2CB	6.25e-04	16	33	2	M47870
Pathway	REACTOME_DARPP_32_EVENTS	PPP2CA PPP2CB	6.25e-04	16	33	2	MM14699
Pathway	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	PPP2CA PPP2CB	6.25e-04	16	33	2	MM14541
Pathway	REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING	PPP2CA PPP2CB	6.25e-04	16	33	2	M514
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	FLNA JUP CTNND1	6.50e-04	73	33	3	MM15126
Pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL	PPP2CA PPP2CB	7.07e-04	17	33	2	MM15096
Pathway	REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE	PPP2CA PPP2CB	7.07e-04	17	33	2	M27083
Pathway	REACTOME_PLATELET_SENSITIZATION_BY_LDL	PPP2CA PPP2CB	7.07e-04	17	33	2	M919
Pathway	REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE	PPP2CA PPP2CB	7.94e-04	18	33	2	MM14759
Pathway	KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY	PPP2CA PPP2CB	8.86e-04	19	33	2	M47525
Pathway	REACTOME_ERK_MAPK_TARGETS	PPP2CA PPP2CB	8.86e-04	19	33	2	MM14780
Pathway	KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING	PPP2CA PPP2CB	9.83e-04	20	33	2	M47876
Pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING	PPP2CA PPP2CB	1.09e-03	21	33	2	M5876
Pathway	PID_ECADHERIN_KERATINOCYTE_PATHWAY	JUP CTNND1	1.09e-03	21	33	2	M184
Pathway	REACTOME_CTLA4_INHIBITORY_SIGNALING	PPP2CA PPP2CB	1.09e-03	21	33	2	MM14996
Pathway	REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	PPP2CA PPP2CB	1.19e-03	22	33	2	M6768
Pathway	KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY	PPP2CA PPP2CB	1.19e-03	22	33	2	M47919
Pathway	REACTOME_ERK_MAPK_TARGETS	PPP2CA PPP2CB	1.19e-03	22	33	2	M13408
Pathway	WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE	PPP2CA INSR	1.30e-03	23	33	2	M45533
Pathway	REACTOME_DARPP_32_EVENTS	PPP2CA PPP2CB	1.42e-03	24	33	2	M751
Pathway	REACTOME_CELL_CELL_COMMUNICATION	FLNA JUP CTNND1	1.44e-03	96	33	3	MM14592
Pathway	REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	PPP2CA PPP2CB	1.54e-03	25	33	2	MM15379
Pathway	REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	PPP2CA PPP2CB	1.54e-03	25	33	2	M808
Pathway	WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY	PPP2CA PPP2CB CTNND1	1.67e-03	101	33	3	MM15829
Pathway	WP_WNT_SIGNALING_AND_PLURIPOTENCY	PPP2CA PPP2CB CTNND1	1.67e-03	101	33	3	M39387
Pathway	REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	JUP CTNND1	1.80e-03	27	33	2	M27422
Pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	PPP2CA PPP2CB	1.80e-03	27	33	2	MM14779
Pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	PPP2CA PPP2CB	1.93e-03	28	33	2	MM15132
Pathway	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	PPP2CA PPP2CB CACNB3	2.02e-03	108	33	3	M17034
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	PPP2CA PPP2CB	2.07e-03	29	33	2	M27528
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	PPP2CA PPP2CB	2.07e-03	29	33	2	MM15253
Pathway	WP_WNT_SIGNALING_PATHWAY	LRP1 PPP2CA JUP	2.13e-03	110	33	3	MM15977
Pathway	REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	JUP CTNND1	2.22e-03	30	33	2	MM15170
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	PPP2CA PPP2CB INSR	2.30e-03	113	33	3	MM14783
Pathway	REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	PPP2CA PPP2CB	2.37e-03	31	33	2	M27400
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING	PPP2CA PPP2CB	2.37e-03	31	33	2	M27529
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING	PPP2CA PPP2CB	2.37e-03	31	33	2	MM15254
Pathway	REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE	PPP2CA PPP2CB	2.37e-03	31	33	2	MM15154
Pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	PPP2CA PPP2CB	2.37e-03	31	33	2	M15195
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	JUP CTNND1	2.52e-03	32	33	2	M48012
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	FLNA JUP CTNND1	2.54e-03	117	33	3	M19248
Pathway	REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK	PPP2CA PPP2CB INSR	2.60e-03	118	33	3	M713
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	PPP2CA PPP2CB JUP CTNND1 INSR	2.68e-03	418	33	5	MM15587
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING	PPP2CA PPP2CB	2.68e-03	33	33	2	M27526
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING	PPP2CA PPP2CB	2.68e-03	33	33	2	MM15252
Pathway	PID_NCADHERIN_PATHWAY	JUP CTNND1	2.68e-03	33	33	2	M266
Pathway	REACTOME_SIGNALING_BY_WNT_IN_CANCER	PPP2CA PPP2CB	2.84e-03	34	33	2	M27405
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING	PPP2CA PPP2CB	2.84e-03	34	33	2	M27527
Pathway	REACTOME_RAF_ACTIVATION	PPP2CA PPP2CB	2.84e-03	34	33	2	M27556
Pathway	WP_GLYCOGEN_METABOLISM	PPP2CA PPP2CB	2.84e-03	34	33	2	MM15985
Pathway	WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME	PPP2CA PPP2CB	2.84e-03	34	33	2	M42555
Pathway	REACTOME_RAF_ACTIVATION	PPP2CA PPP2CB	3.01e-03	35	33	2	MM15271
Pathway	REACTOME_REGULATION_OF_TP53_DEGRADATION	PPP2CA PPP2CB	3.19e-03	36	33	2	MM15339
Pathway	REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION	PPP2CA PPP2CB	3.36e-03	37	33	2	M27641
Pathway	REACTOME_SIGNALING_BY_FGFR3	PPP2CA PPP2CB	3.73e-03	39	33	2	MM15257
Pathway	PID_ECADHERIN_NASCENT_AJ_PATHWAY	JUP CTNND1	3.73e-03	39	33	2	M156
Pathway	WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION	PPP2CA PPP2CB	3.92e-03	40	33	2	M39595
Pathway	REACTOME_SIGNALING_BY_FGFR3	PPP2CA PPP2CB	3.92e-03	40	33	2	M27532
Pathway	REACTOME_SIGNALING_BY_FGFR4	PPP2CA PPP2CB	3.92e-03	40	33	2	MM15258
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	JUP CTNND1	3.92e-03	40	33	2	MM15060
Pathway	REACTOME_SIGNALING_BY_FGFR4	PPP2CA PPP2CB	4.12e-03	41	33	2	M27533
Pathway	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	PPP2CA PPP2CB	4.32e-03	42	33	2	MM15274
Pathway	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	PPP2CA PPP2CB	4.52e-03	43	33	2	M27560
Pathway	REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1	PPP2CA PPP2CB	4.73e-03	44	33	2	MM15377
Pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	PPP2CA PPP2CB FLNA	5.19e-03	151	33	3	M550
Pathway	REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1	PPP2CA PPP2CB	5.38e-03	47	33	2	M29724
Pathway	REACTOME_CELL_CELL_COMMUNICATION	FLNA JUP CTNND1	5.59e-03	155	33	3	M522
Pathway	PID_AJDISS_2PATHWAY	JUP CTNND1	5.60e-03	48	33	2	M142
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	JUP CTNND1	5.60e-03	48	33	2	MM15069
Pathway	REACTOME_SIGNALING_BY_FGFR1	PPP2CA PPP2CB	6.07e-03	50	33	2	MM15255
Pathway	REACTOME_SIGNALING_BY_FGFR1	PPP2CA PPP2CB	6.55e-03	52	33	2	M27530
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	LRP1 CACNB3 CHD1L CTNND1 DPP9 KIF1A INPP5A WNK2 NOTCH2 PPP1R9A ANKAR INSR	3.49e-08	1489	38	12	28611215
Pubmed	Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.	PPP2CA PPP2CB	1.16e-06	2	38	2	2555176
Pubmed	The role of protein phosphatase 2A catalytic subunit Calpha in embryogenesis: evidence from sequence analysis and localization studies.	PPP2CA PPP2CB	1.16e-06	2	38	2	10543450
Pubmed	Regulation of spindle formation by active mitogen-activated protein kinase and protein phosphatase 2A during mouse oocyte meiosis.	PPP2CA PPP2CB	1.16e-06	2	38	2	11751260
Pubmed	Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities.	PPP2CA PPP2CB	1.16e-06	2	38	2	34902541
Pubmed	Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.	PPP2CA PPP2CB	1.16e-06	2	38	2	2837763
Pubmed	Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.	PPP2CA PPP2CB	1.16e-06	2	38	2	1846293
Pubmed	PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte.	PPP2CA PPP2CB	1.16e-06	2	38	2	27096707
Pubmed	Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9.	DPP4 DPP9	1.16e-06	2	38	2	22001206
Pubmed	Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.	PPP2CA PPP2CB	1.16e-06	2	38	2	11113010
Pubmed	Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway.	FLNA INSR	1.16e-06	2	38	2	12734206
Pubmed	Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.	CCDC50 JUP CTNND1 INSR	1.39e-06	75	38	4	15951569
Pubmed	Isoforms of dipeptidyl aminopeptidase IV from Pseudomonas sp. WO24: role of the signal sequence and overexpression in Escherichia coli.	DPP4 DPP9	3.48e-06	3	38	2	15866709
Pubmed	The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.	DPP4 DPP9	3.48e-06	3	38	2	29693275
Pubmed	The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo.	PPP2CA PPP2CB	3.48e-06	3	38	2	8206937
Pubmed	Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts.	PPP2CA PPP2CB	3.48e-06	3	38	2	7510677
Pubmed	Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.	DPP4 DPP9	3.48e-06	3	38	2	23608773
Pubmed	Low density lipoprotein receptor-related protein 1 promotes anti-apoptotic signaling in neurons by activating Akt survival pathway.	LRP1 INSR	3.48e-06	3	38	2	19815552
Pubmed	Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis.	DPP4 DPP9	3.48e-06	3	38	2	16704418
Pubmed	Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the alpha 4 subunit which promotes dephosphorylation of elongation factor-2.	PPP2CA PPP2CB	3.48e-06	3	38	2	10441131
Pubmed	Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function.	PPP2CA PPP2CB	3.48e-06	3	38	2	23341017
Pubmed	Localization of the genes encoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23-->q31 and 8p12-->p11.2, respectively.	PPP2CA PPP2CB	3.48e-06	3	38	2	8383590
Pubmed	Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.	PPP2CA PPP2CB	3.48e-06	3	38	2	15252037
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	JUP CTNND1 SBF1 NOTCH2 PPP1R9A INSR	6.04e-06	421	38	6	36976175
Pubmed	The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.	LRP1 FLNA	6.96e-06	4	38	2	27522265
Pubmed	Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.	DPP4 DPP9	6.96e-06	4	38	2	20043068
Pubmed	Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.	PPP2CA PPP2CB	6.96e-06	4	38	2	11371618
Pubmed	The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.	PPP2CA PPP2CB	6.96e-06	4	38	2	21454489
Pubmed	Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes.	JUP CTNND1	6.96e-06	4	38	2	7876318
Pubmed	The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic.	PPP2CA PPP2CB	6.96e-06	4	38	2	14633983
Pubmed	LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.	LRP1 NOTCH2	6.96e-06	4	38	2	38462037
Pubmed	Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse.	PPP2CA PPP2CB	6.96e-06	4	38	2	21998041
Pubmed	Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.	JUP CTNND1	6.96e-06	4	38	2	18837082
Pubmed	Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha.	PPP2CA PPP2CB	6.96e-06	4	38	2	9770493
Pubmed	DPP9 is a novel component of the N-end rule pathway targeting the tyrosine kinase Syk.	FLNA DPP9	6.96e-06	4	38	2	27614019
Pubmed	Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain.	PPP2CA PPP2CB	6.96e-06	4	38	2	7616230
Pubmed	Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain.	PPP2CA PPP2CB	6.96e-06	4	38	2	9920888
Pubmed	Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release.	LRP1 JMJD6	6.96e-06	4	38	2	15647754
Pubmed	Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia.	JUP CTNND1	1.16e-05	5	38	2	7542250
Pubmed	The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or alpha-catenin.	JUP CTNND1	1.16e-05	5	38	2	7651399
Pubmed	N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane.	JUP CTNND1	1.16e-05	5	38	2	12604612
Pubmed	Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain.	PPP2CA PPP2CB	1.16e-05	5	38	2	10640627
Pubmed	Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia.	DPP4 DPP9	1.16e-05	5	38	2	20534982
Pubmed	Expression and interaction of different catenins in colorectal carcinoma cells.	JUP CTNND1	1.16e-05	5	38	2	11712088
Pubmed	Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.	DPP4 DPP9	1.16e-05	5	38	2	23704821
Pubmed	Trim32 reduces PI3K-Akt-FoxO signaling in muscle atrophy by promoting plakoglobin-PI3K dissociation.	JUP INSR	1.16e-05	5	38	2	24567360
Pubmed	HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint.	PPP2CA PPP2CB	1.16e-05	5	38	2	9009195
Pubmed	Protein phosphatase 2A interacts with and directly dephosphorylates RelA.	PPP2CA PPP2CB	1.16e-05	5	38	2	11591705
Pubmed	Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice.	PPP2CA PPP2CB	1.16e-05	5	38	2	18596935
Pubmed	Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development.	PPP2CA PPP2CB	1.74e-05	6	38	2	10781942
Pubmed	Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A.	PPP2CA PPP2CB	1.74e-05	6	38	2	20100830
Pubmed	Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis.	PPP2CA PPP2CB	1.74e-05	6	38	2	29735529
Pubmed	Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex.	JUP CTNND1	1.74e-05	6	38	2	11226248
Pubmed	Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications.	PPP2CA PPP2CB	1.74e-05	6	38	2	15147202
Pubmed	STRIPAK components determine mode of cancer cell migration and metastasis.	PPP2CA PPP2CB	1.74e-05	6	38	2	25531779
Pubmed	Alpha 4 associates with protein phosphatases 2A, 4, and 6.	PPP2CA PPP2CB	1.74e-05	6	38	2	9647778
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PPP2CB FLNA JUP CTNND1 SBF1 WNK2 PPP1R9A EIF3L NUAK2	1.82e-05	1431	38	9	37142655
Pubmed	The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development.	PPP2CA PPP2CB	2.43e-05	7	38	2	25546391
Pubmed	X-linked microtubule-associated protein, Mid1, regulates axon development.	PPP2CA PPP2CB	2.43e-05	7	38	2	24194544
Pubmed	GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.	PPP2CA PPP2CB	2.43e-05	7	38	2	10698523
Pubmed	Protein phosphatase 2A and separase form a complex regulated by separase autocleavage.	PPP2CA PPP2CB	2.43e-05	7	38	2	17604273
Pubmed	Gamma-secretase-dependent and -independent effects of presenilin1 on beta-catenin.Tcf-4 transcriptional activity.	JUP CTNND1	2.43e-05	7	38	2	19114997
Pubmed	The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn).	JUP CTNND1	2.43e-05	7	38	2	12370829
Pubmed	Relevance Rank Platform (RRP) for Functional Filtering of High Content Protein-Protein Interaction Data.	PPP2CA PPP2CB FLNA	2.56e-05	52	38	3	26499835
Pubmed	Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.	CTNND1 SBF1 KIF1A NOTCH2	2.82e-05	160	38	4	31678930
Pubmed	Claudin-4 localization in epithelial ovarian cancer.	JUP CTNND1 NOTCH2	2.87e-05	54	38	3	36237976
Pubmed	p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected].	PPP2CA PPP2CB	3.24e-05	8	38	2	1330687
Pubmed	Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A.	PPP2CA PPP2CB	3.24e-05	8	38	2	12912990
Pubmed	Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.	PPP2CA PPP2CB	3.24e-05	8	38	2	35768646
Pubmed	Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution.	PPP2CA PPP2CB	3.24e-05	8	38	2	12370081
Pubmed	The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton.	JUP CTNND1	3.24e-05	8	38	2	9535896
Pubmed	Type 2A protein phosphatase, the complex regulator of numerous signaling pathways.	PPP2CA PPP2CB	3.24e-05	8	38	2	11007961
Pubmed	Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.	PPP2CA PPP2CB	3.24e-05	8	38	2	16262633
Pubmed	Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons.	PPP2CA PPP2CB	3.24e-05	8	38	2	23462102
Pubmed	Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP-2A in mouse eye.	PPP2CA PPP2CB	4.16e-05	9	38	2	18432318
Pubmed	Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2.	PCDH15 NOTCH2	4.16e-05	9	38	2	23144817
Pubmed	The role of notch signaling in the development of intrahepatic bile ducts.	DPP4 NOTCH2	4.16e-05	9	38	2	15578515
Pubmed	Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital.	PPP2CA PPP2CB	4.16e-05	9	38	2	12885400
Pubmed	Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.	PPP2CA FLNA	4.16e-05	9	38	2	11114196
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	TUBGCP6 PPP2CA PPP2CB CHD1L CTNND1 DPP9	4.69e-05	606	38	6	36538041
Pubmed	A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells.	JUP CTNND1	6.35e-05	11	38	2	14625392
Pubmed	Igf1r signaling is indispensable for preimplantation development and is activated via a novel function of E-cadherin.	JUP CTNND1	6.35e-05	11	38	2	22479204
Pubmed	MARF1 regulates essential oogenic processes in mice.	PPP2CA PPP2CB	6.35e-05	11	38	2	22442484
Pubmed	Streamlined analysis schema for high-throughput identification of endogenous protein complexes.	INTS6L PPP2CA PPP2CB	6.53e-05	71	38	3	20133760
Pubmed	Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5.	PPP2CA PPP2CB	7.62e-05	12	38	2	12435421
Pubmed	Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT).	JUP CTNND1	7.62e-05	12	38	2	16973135
Pubmed	Regulation of cochlear convergent extension by the vertebrate planar cell polarity pathway is dependent on p120-catenin.	PCDH15 CTNND1	7.62e-05	12	38	2	22318628
Pubmed	Defining desmosomal plakophilin-3 interactions.	JUP CTNND1	7.62e-05	12	38	2	12707304
Pubmed	Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication.	PPP2CA PPP2CB	7.62e-05	12	38	2	11259605
Pubmed	PP2A in LepR+ mesenchymal stem cells contributes to embryonic and postnatal endochondral ossification through Runx2 dephosphorylation.	PPP2CA PPP2CB	7.62e-05	12	38	2	34079065
Pubmed	The ins and outs of HIV-1 Tat.	LRP1 DPP4	7.62e-05	12	38	2	21951552
Pubmed	PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum.	PPP2CA PPP2CB	9.00e-05	13	38	2	16717086
Pubmed	Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.	PPP2CA PPP2CB	9.00e-05	13	38	2	18971272
Pubmed	PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.	PPP2CA PPP2CB	9.00e-05	13	38	2	21072166
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	LRP1 DPP4 SBF1 KIF1A INSR	9.07e-05	420	38	5	28065597
Pubmed	Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr.	PPP2CA PPP2CB	1.05e-04	14	38	2	9013886
Pubmed	Loss of mXinalpha, an intercalated disk protein, results in cardiac hypertrophy and cardiomyopathy with conduction defects.	JUP CTNND1	1.05e-04	14	38	2	17766470
Pubmed	Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.	PPP2CA PPP2CB	1.05e-04	14	38	2	9400615
Pubmed	Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.	JUP CTNND1	1.21e-04	15	38	2	18393386
Pubmed	Deletion of Sarcolemmal Membrane-Associated Protein Isoform 3 (SLMAP3) in Cardiac Progenitors Delays Embryonic Growth of Myocardium without Affecting Hippo Pathway.	PPP2CA PPP2CB	1.21e-04	15	38	2	38474134
Interaction	TAFA3 interactions	PPP2CA DPP9 KIF1A INSR	1.39e-05	78	38	4	int:TAFA3
Interaction	PPP1R9B interactions	PPP2CA DPP4 PPP2CB FLNA JUP CACNB3 PPP1R9A NUAK2	1.78e-05	626	38	8	int:PPP1R9B
Interaction	SRC interactions	LRP1 DPP4 PPP2CB FLNA JUP CTNND1 EFS INSR	2.71e-05	664	38	8	int:SRC
Interaction	GAD1 interactions	PPP2CA PPP2CB JMJD6	4.60e-05	37	38	3	int:GAD1
Interaction	CAV1 interactions	LRP1 PPP2CA FLNA JUP CTNND1 NOTCH2 PPP1R9A INSR	5.02e-05	724	38	8	int:CAV1
Interaction	INTS6 interactions	INTS6L LRP1 PPP2CA PPP2CB	5.38e-05	110	38	4	int:INTS6
Interaction	WNT3A interactions	LRP1 NOTCH2 INSR	1.07e-04	49	38	3	int:WNT3A
Interaction	FOXD4L6 interactions	TUBGCP6 PPP2CA NOTCH2	1.07e-04	49	38	3	int:FOXD4L6
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	TUBGCP6 CELSR1 SBF1 EIF3L	1.60e-04	330	38	4	chr22q13
Cytoband	12p13.3	ANO2 PRMT8	2.86e-04	30	38	2	12p13.3
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	JUP CTNND1 ANKAR	3.94e-05	43	28	3	409
GeneFamily	CD molecules\|DASH family	DPP4 DPP9	4.83e-05	7	28	2	1205
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP2CA PPP2CB	1.79e-04	13	28	2	693
GeneFamily	Protein phosphatase catalytic subunits\|STRIPAK complex	PPP2CA PPP2CB	4.32e-04	20	28	2	1371
GeneFamily	Actins\|Deafness associated genes	PCDH15 CCDC50	1.32e-02	113	28	2	1152
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	LRP1 DPP4 INSR	2.25e-02	394	28	3	471
GeneFamily	Fibronectin type III domain containing	MYOM1 INSR	2.53e-02	160	28	2	555
Coexpression	GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	INTS6L CELSR1 MYOM1 INPP5A INSR	9.82e-06	199	38	5	M7491
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	DPP4 WNK2 NOTCH2 PPP1R9A INSR	6.66e-07	196	38	5	057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DPP4 WNK2 NOTCH2 PPP1R9A INSR	6.83e-07	197	38	5	3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 AEBP1 WNK2	1.41e-05	173	38	4	fc2602b2ce051cd4c33957d7e3d041ff8a529883
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 AEBP1 WNK2	1.41e-05	173	38	4	901b8e6909c1f3849906fad9cee17b8f0bab050d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JUP LAT2 INPP5A NUAK2	1.51e-05	176	38	4	dde46f06f6fc3f7ba83be91a0ee6231790955e3e
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CELSR1 PRMT8 WNK2 PPP1R9A	1.83e-05	185	38	4	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CELSR1 PRMT8 WNK2 INSR	1.91e-05	187	38	4	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-B_cell-B_cell\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC50 JUP CELSR1 NUAK2	1.95e-05	188	38	4	99fdd305f75ed38dd507e7a17ffe27c26b86e454
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-B_cell\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC50 JUP CELSR1 NUAK2	1.95e-05	188	38	4	5a0519b189e96001d95f9d24363448e8602b8d4d
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-B_cell-B_cell-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CCDC50 JUP CELSR1 NUAK2	1.95e-05	188	38	4	e8b7c1c2eb2e390ad79b358236468b0f15ea58a5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 INPP5A WNK2	1.99e-05	189	38	4	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 INPP5A WNK2	1.99e-05	189	38	4	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 INPP5A WNK2	1.99e-05	189	38	4	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	CELSR1 WNK2 PPP1R9A INSR	1.99e-05	189	38	4	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 INPP5A WNK2	1.99e-05	189	38	4	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CELSR1 PRMT8 WNK2 INSR	2.03e-05	190	38	4	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA MYOM1 INPP5A WNK2	2.08e-05	191	38	4	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDH15 LRP1 AEBP1 NOTCH2	2.08e-05	191	38	4	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	facs-Lung-EPCAM-18m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 FLNA AEBP1 NOTCH2	2.16e-05	193	38	4	b9ac74357435f2f24aaede62b2a1d31b5d96a12c
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CELSR1 PRMT8 WNK2 PPP1R9A	2.16e-05	193	38	4	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	JUP CELSR1 WNK2 INSR	2.21e-05	194	38	4	0cd4363627acd419e00d6d32f6dce10430aa6487
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRP1 DPP4 PPP2CB AEBP1	2.21e-05	194	38	4	08fad7591c20568de797cf8e206de2d0b1d78aab
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	JUP AEBP1 LAT2 NUAK2	2.21e-05	194	38	4	4a4cc61193344bb151439f63d0584abddde47cf0
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	JUP CELSR1 WNK2 INSR	2.21e-05	194	38	4	a58841b34efe673671a9a059238e044a7254b279
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA MYOM1 INPP5A WNK2	2.21e-05	194	38	4	b8a130ffae68ffe550bf335460a1ec1035cf8d8d
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 CELSR1 WNK2 INSR	2.25e-05	195	38	4	2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1 FLNA AEBP1 HEPH	2.25e-05	195	38	4	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 WNK2 PPP1R9A INSR	2.25e-05	195	38	4	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 CELSR1 WNK2 INSR	2.25e-05	195	38	4	576142b4e75457c0973051bccc4163bd624496af
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1 FLNA AEBP1 HEPH	2.25e-05	195	38	4	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 CELSR1 WNK2 INSR	2.25e-05	195	38	4	8f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCell	IIH-mDC2-\|IIH / Condition, Cell_class and T cell subcluster	CCDC50 CTNND1 LAT2 INSR	2.25e-05	195	38	4	ed4fcd51d523d960bf3650bf284d400007e55714
ToppCell	IIH-mDC2\|IIH / Condition, Cell_class and T cell subcluster	CCDC50 CTNND1 LAT2 INSR	2.25e-05	195	38	4	4146912b69041cc1505ddba4125c8e10e0125329
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 AEBP1 WNK2	2.30e-05	196	38	4	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 CELSR1 WNK2 INSR	2.30e-05	196	38	4	8e909c31733762646359fe78b645cbd60237459e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 AEBP1 WNK2	2.30e-05	196	38	4	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	VE-mDC2-\|VE / Condition, Cell_class and T cell subcluster	CCDC50 CTNND1 LAT2 INSR	2.34e-05	197	38	4	6629588819ec31a7e4f33b94b8c035145a5f6c17
ToppCell	VE-mDC2\|VE / Condition, Cell_class and T cell subcluster	CCDC50 CTNND1 LAT2 INSR	2.34e-05	197	38	4	e3172102ad17c92c3038cad37bf933eb04351048
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CELSR1 PRMT8 WNK2 INSR	2.39e-05	198	38	4	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FLNA MYOM1 AEBP1 IRX4	2.44e-05	199	38	4	8ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDH15 LRP1 CCDC50 PPP1R9A	2.44e-05	199	38	4	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	PPP2CB CELSR1 NOTCH2 NUAK2	2.44e-05	199	38	4	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CTNND1 ALOX15B INSR	1.64e-04	125	38	3	a72891c3fb9cdefa9254f8e2e3c4ffa6fc3a5ffc
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CELSR1 LAT2 INSR	2.39e-04	142	38	3	e5608bbbc04edcdaafe1affc4db7f9d8edba04d9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PCDH15 CCDC50 PRMT8	2.50e-04	144	38	3	fca32b38d23fa4d213e553b929604a2796e9a929
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH15 WNK2 ANKAR	2.55e-04	145	38	3	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYOM1 ALOX15B NUAK2	2.76e-04	149	38	3	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	Pericytes-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	AEBP1 EFS HEPH	2.81e-04	150	38	3	dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59
ToppCell	Healthy_donor-B_cell\|World / disease group, cell group and cell class (v2)	CELSR1 INPP5A PPP1R9A	2.81e-04	150	38	3	a2dfed562de7f58f902b547acec5a13853c80c4c
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYOM1 ALOX15B NUAK2	2.81e-04	150	38	3	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	Leuk-UTI-Lymphocyte-T_NK-MAIT\|Leuk-UTI / Disease, Lineage and Cell Type	DPP4 GPR15 PPP1R9A	2.98e-04	153	38	3	ac3a1d1b5bf6009df818fd757dad7382d95c60dc
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ANO2 LHX5 IRX4	3.04e-04	154	38	3	df1b58a20af73fa79c6c069c0117a9ffd85b476f
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR15 LAT2 ALOX15B	3.10e-04	155	38	3	c648512305166d2a2f0e284c127bc802af908071
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDH15 CCDC50 PPP1R9A	3.10e-04	155	38	3	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 AEBP1	3.16e-04	156	38	3	d5207dbfbcfb885557ea1378dfe6a56d7102e94a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLNA MYOM1 AEBP1	3.16e-04	156	38	3	363f1b661048d25895e2b8681c82894c957b29c0
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	JUP AEBP1 LAT2	3.16e-04	156	38	3	b093dbba6662e4fffc8aa577587b77f64ac44b56
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 NOTCH2 NUAK2	3.28e-04	158	38	3	b0508a600994090c6aafd8d779437190a33ad821
ToppCell	facs-Lung-EPCAM-3m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 NOTCH2 NUAK2	3.28e-04	158	38	3	ef5feb48161c339c7b71c576bdda61479d29dfac
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 NOTCH2 NUAK2	3.28e-04	158	38	3	c6e64b9b3342e37d54baadae8fb7dfb5d246e4cf
ToppCell	facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 NOTCH2 NUAK2	3.28e-04	158	38	3	a816cc095452308d06f87b77467e2a8c6361fd2a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AEBP1 EFS INSR	3.40e-04	160	38	3	778faada072e3abfa76a9a06fd4885fb63de7902
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CELSR1 WNK2 INSR	3.46e-04	161	38	3	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDH15 WNK2 ANKAR	3.52e-04	162	38	3	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Bronchial-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KIF1A HEPH PPP1R9A	3.52e-04	162	38	3	afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCell	Club_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	CELSR1 KIF1A WNK2	3.65e-04	164	38	3	4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5
ToppCell	facs-MAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR1 ANKAR ALOX15B	3.65e-04	164	38	3	e9e34c305c943675688e54ab331c2bdefb2fac68
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CELSR1 PRMT8 PPP1R9A	3.72e-04	165	38	3	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CELSR1 PRMT8 PPP1R9A	3.72e-04	165	38	3	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CELSR1 WNK2 NUAK2	3.72e-04	165	38	3	f6887c64af0f26e33316bc5587487e24d76ece2a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 WNK2 INSR	3.78e-04	166	38	3	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	severe-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CCDC50 DPP4 AEBP1	3.78e-04	166	38	3	ae38850fde549b8dd6fb12f0ef80b428ade50485
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 WNK2 INSR	3.78e-04	166	38	3	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 WNK2 INSR	3.78e-04	166	38	3	4586d6725403f879fc96f67be579022587ce1906
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	JUP IRX4 PPP1R9A	3.78e-04	166	38	3	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MYOM1 AEBP1	3.85e-04	167	38	3	784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	JUP IRX4 PPP1R9A	3.85e-04	167	38	3	3ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRP1 FLNA NUAK2	3.92e-04	168	38	3	c861f80aa12caf54a94d93e38539ff41dc5227a6
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CELSR1 WNK2 INSR	3.99e-04	169	38	3	40b557549fe08c5dc9dba359af35993d68d1640a
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDH15 MYOM1 AEBP1	3.99e-04	169	38	3	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	facs-Heart-RV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 DPP4 AEBP1	4.06e-04	170	38	3	d7c9a604311974ff87ece43a0f8725a234d262f7
ToppCell	368C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CCDC50 DPP4 MYOM1	4.13e-04	171	38	3	714a0b0d0c9886fef64170cf53eb64f0d8a47280
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOM1 AEBP1 NOTCH2	4.13e-04	171	38	3	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	droplet-Pancreas-Exocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA AEBP1 NOTCH2	4.13e-04	171	38	3	92ac4cc3d54da2ea8e202aa59c78e8875356649e
ToppCell	facs-BAT-Fat-18m-Myeloid-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 FLNA NUAK2	4.20e-04	172	38	3	36fe66a8c0aecee7a19269be23210c0ed7abb155
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	DPP4 CACNB3 PRMT8	4.20e-04	172	38	3	a126dacd94939851de1403d30f0b63eaad48bfa1
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB3 LHX5 KIF1A	4.20e-04	172	38	3	c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNB3 LHX5 KIF1A	4.20e-04	172	38	3	48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e
ToppCell	facs-Lung-EPCAM-18m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB3 LHX5 KIF1A	4.20e-04	172	38	3	7c085c02b59e24e2a2cd393b5e692f9fb19257fe
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L FLNA MYOM1	4.27e-04	173	38	3	2415b6ff49f334da570577d4e93484d024a3dbd5
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L LAT2 ALOX15B	4.27e-04	173	38	3	3612772632ddf11eb48579cae9a8ccab6b3f1f52
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L FLNA MYOM1	4.27e-04	173	38	3	2acd0693a2dfe04e3c1b2125ea63efe92d13150b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L LAT2 ALOX15B	4.27e-04	173	38	3	4dc261ebcdb9bdcfca1451da1bd254f0dc5de203
ToppCell	critical-Epithelial-unknown_epithelial\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FLNA LAT2 JMJD6	4.27e-04	173	38	3	4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR15 LAT2 ALOX15B	4.27e-04	173	38	3	2cba41c3d9d3076f703115d19729073a3ac3feb6
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR15 LAT2 ALOX15B	4.27e-04	173	38	3	11d69a4ab4a87b8820cd3bd204de8c4124450a90
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCDH15 CELSR1 PPP1R9A	4.34e-04	174	38	3	e2243f1e48e3275753a2b3a69d06eefce69a8ded
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC50 LAT2 NOTCH2	4.34e-04	174	38	3	2f4bc0275cbcaa830d04a4c76e042456908d2277
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRP1 FLNA CHD1L	4.34e-04	174	38	3	d5c22b43531414951666ee7542a66ed9380e2d14
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC50 LAT2 NOTCH2	4.34e-04	174	38	3	01eff218e71a04201189a0313aaf91437fffed95
Drug	C5-substituted pyrrolidine 31	DPP4 DPP9	2.57e-06	2	37	2	CID010339570
Drug	SureCN3749646	DPP4 DPP9	7.70e-06	3	37	2	CID011530920
Drug	SureCN3745540	DPP4 DPP9	7.70e-06	3	37	2	CID011974437
Drug	SureCN3749947	DPP4 DPP9	7.70e-06	3	37	2	CID011974435
Drug	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	KIF1A INSR	7.70e-06	3	37	2	DB03909
Drug	ABT-279	DPP4 DPP9	7.70e-06	3	37	2	CID016049769
Drug	Cyanopyrrolidine 38	DPP4 DPP9	7.70e-06	3	37	2	CID010932707
Drug	Cyanopyrrolidine 39	DPP4 DPP9	7.70e-06	3	37	2	CID011117606
Drug	SureCN3748611	DPP4 DPP9	7.70e-06	3	37	2	CID011974325
Drug	Diprolyl-alanine	DPP4 DPP9	7.70e-06	3	37	2	CID000193559
Drug	2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A	LRP1 DPP4 CACNB3 CELSR1 PPP1R9A	1.49e-05	194	37	5	6173_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; HL60; HT_HG-U133A	LRP1 DPP4 PRMT8 EFS IRX4	1.53e-05	195	37	5	2544_UP
Drug	glycylproline 4-nitroanilide	DPP4 DPP9	1.54e-05	4	37	2	ctd:C042892
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; HL60; HT_HG-U133A	JUP CACNB3 CTNND1 SBF1 JMJD6	1.60e-05	197	37	5	2526_DN
Drug	Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A	DPP4 CHD1L CTNND1 LAT2 NOTCH2	1.60e-05	197	37	5	4800_UP
Drug	prodipine	DPP4 DPP9	2.56e-05	5	37	2	CID000065775
Drug	arginyl(PMC)-pyrrolidine-2-nitrile	DPP4 DPP9	2.56e-05	5	37	2	CID000487437
Drug	alanylproline-4-nitroanilide	DPP4 DPP9	2.56e-05	5	37	2	ctd:C083013
Drug	cathepsin C substrate	DPP4 DPP9	3.84e-05	6	37	2	CID003508173
Drug	NVP-DPP728	DPP4 DPP9	3.84e-05	6	37	2	CID009796290
Drug	MK-251	DPP4 DPP9	3.84e-05	6	37	2	CID000176160
Drug	II 19	DPP4 DPP9	3.84e-05	6	37	2	CID000040321
Drug	AC1L1UOE	DPP4 DPP9 NOTCH2	4.04e-05	41	37	3	CID000010191
Drug	Epostatin	DPP4 DPP9	5.37e-05	7	37	2	CID006449105
Drug	o-Py	DPP4 DPP9	5.37e-05	7	37	2	CID009942336
Drug	CID6451162	DPP4 DPP9	7.15e-05	8	37	2	CID006451162
Drug	P32/98	DPP4 DPP9	7.15e-05	8	37	2	CID006918464
Drug	imidazolelactate	DPP4 DPP9	7.15e-05	8	37	2	CID000000793
Drug	NSC-334212	DPP4 DPP9	9.18e-05	9	37	2	CID000333414
Drug	Gly-pro-na	DPP4 DPP9	9.18e-05	9	37	2	CID000194319
Drug	Appna	DPP4 DPP9	9.18e-05	9	37	2	CID006453929
Drug	Phe-pro-ala	DPP4 DPP9	9.18e-05	9	37	2	CID000133668
Drug	SureCN475872	DPP4 DPP9	9.18e-05	9	37	2	CID011163584
Drug	Manganese	DPP4 CELSR1 MYOM1 LAT2 HEPH INSR	1.14e-04	480	37	6	ctd:D008345
Drug	N-phenylphthalimide	DPP4 DPP9	1.15e-04	10	37	2	CID000068215
Drug	Vitamin E	PPP2CA PPP2CB	1.15e-04	10	37	2	DB00163
Drug	Hxp	DPP4 DPP9	1.15e-04	10	37	2	CID000449159
Drug	X1043	DPP4 DPP9	1.15e-04	10	37	2	CID011235728
Drug	PMSA	DPP4 FLNA	1.40e-04	11	37	2	CID000125605
Drug	Kiq	DPP4 DPP9	1.98e-04	13	37	2	CID011974439
Drug	sampatrilat	DPP4 DPP9	1.98e-04	13	37	2	CID006324648
Drug	4-nitroaniline	DPP4 DPP9	1.98e-04	13	37	2	ctd:C019498
Drug	UCF 101	PPP2CA PPP2CB	1.98e-04	13	37	2	ctd:C501517
Drug	Gly-pro-mca	DPP4 DPP9	1.98e-04	13	37	2	CID000125640
Drug	AC1MHZPD	DPP4 DPP9	2.31e-04	14	37	2	CID003035635
Drug	7-amino-4-trifluoromethylcoumarin	DPP4 DPP9	2.31e-04	14	37	2	CID000100641
Drug	1-undecanol	EFS ALOX15B	2.31e-04	14	37	2	CID000008184
Drug	AC1L4NWK	DPP4 DPP9	2.66e-04	15	37	2	CID000189017
Drug	AC1L322F	DPP4 DPP9	2.66e-04	15	37	2	CID000133040
Drug	Alsterpaullone; Up 200; 10uM; MCF7; HT_HG-U133A	SBF1 KIF1A LAT2 JMJD6	2.71e-04	194	37	4	7051_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	GPR15 KIF1A LAT2 INSR	2.76e-04	195	37	4	6967_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	DPP4 LAT2 PPP1R9A INSR	2.76e-04	195	37	4	4736_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A	CACNB3 KIF1A JMJD6 NUAK2	2.82e-04	196	37	4	7155_UP
Drug	PF-00539745-00 [351321-33-0]; Up 200; 10uM; MCF7; HT_HG-U133A	KIF1A LAT2 NOTCH2 PPP1R9A	2.87e-04	197	37	4	5974_UP
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	CACNB3 CELSR1 KIF1A IRX4	2.87e-04	197	37	4	6935_DN
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	PPP2CB ANO2 CELSR1 PPP1R9A	2.87e-04	197	37	4	5685_UP
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A	KIF1A LAT2 ALOX15B INSR	2.87e-04	197	37	4	5803_UP
Drug	(R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A	DPP4 GPR15 LAT2 EFS	2.93e-04	198	37	4	4841_UP
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A	ANO2 GPR15 IRX4 ALOX15B	2.93e-04	198	37	4	5805_UP
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A	PPP2CB LAT2 INSR NUAK2	2.93e-04	198	37	4	3788_UP
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	CACNB3 SBF1 KIF1A NUAK2	2.93e-04	198	37	4	7130_UP
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	CACNB3 SBF1 KIF1A JMJD6	2.93e-04	198	37	4	3259_DN
Drug	Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A	ANO2 PRMT8 HEPH ALOX15B	2.93e-04	198	37	4	4603_UP
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A	CHD1L CTNND1 SBF1 KIF1A	2.93e-04	198	37	4	1482_DN
Drug	vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A	DPP4 CACNB3 CHD1L SBF1	2.93e-04	198	37	4	7556_DN
Drug	Gliquidone [33342-05-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	LRP1 SBF1 LAT2 JMJD6	2.98e-04	199	37	4	6505_UP
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CACNB3 CTNND1 SBF1 IRX4	2.98e-04	199	37	4	7192_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	CACNB3 AEBP1 IRX4 NOTCH2	2.98e-04	199	37	4	7552_DN
Drug	Skimmianine [83-95-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ANO2 PRMT8 KIF1A LAT2	2.98e-04	199	37	4	5766_UP
Drug	Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; PC3; HT_HG-U133A	LRP1 CACNB3 GPR15 KIF1A	2.98e-04	199	37	4	5754_UP
Drug	Chlorine	PPP2CA DPP4 PPP2CB JUP CACNB3	3.02e-04	367	37	5	ctd:D002713
Drug	FLEC	DPP4 EFS	3.04e-04	16	37	2	CID000115102
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	ANO2 LAT2 JMJD6 HEPH	3.04e-04	200	37	4	3968_UP
Drug	Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A	PPP2CB ANO2 GPR15 LAT2	3.04e-04	200	37	4	6057_UP
Drug	Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A	DPP4 SBF1 ALOX15B INSR	3.04e-04	200	37	4	6002_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; HL60; HT_HG-U133A	LRP1 DPP4 GPR15 IRX4	3.04e-04	200	37	4	2987_UP
Drug	Panthenol (D) [81-13-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	PPP2CB SBF1 KIF1A LAT2	3.04e-04	200	37	4	7455_UP
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	KIF1A NOTCH2 INSR NUAK2	3.04e-04	200	37	4	6612_DN
Drug	Arg-pro	DPP4 DPP9 INSR	3.20e-04	82	37	3	CID000151003
Drug	pyrrolidinium	DPP4 DPP9 NOTCH2	3.56e-04	85	37	3	CID000031268
Drug	l-alanyl-l-proline	DPP4 CHD1L DPP9	3.81e-04	87	37	3	CID000083525
Drug	europium	FLNA HEPH INSR	3.81e-04	87	37	3	CID000023981
Drug	coproporphyrin I	DPP4 DPP9	3.87e-04	18	37	2	CID000068271
Drug	His-Ser	DPP4 DPP9	3.87e-04	18	37	2	CID000435727
Drug	4,4'-DBP	JUP SBF1	4.32e-04	19	37	2	CID000007034
Drug	beta-methylphenylalanine	DPP4 DPP9	5.29e-04	21	37	2	CID000064808
Drug	26 C	DPP4 DPP9	5.29e-04	21	37	2	CID005327159
Drug	beta-Casomorphin 4	DPP4 DPP9	5.29e-04	21	37	2	CID000173253
Drug	diphenyl phosphonate	DPP4 DPP9	5.29e-04	21	37	2	CID006327546
Drug	Trp-Ala	DPP4 DPP9	6.36e-04	23	37	2	CID000263475
Drug	tosylate	DPP4 DPP9	6.36e-04	23	37	2	CID000006101
Drug	phaeophytin-a	CACNB3 EFS HEPH	6.61e-04	105	37	3	CID005351507
Drug	AC1L320U	PPP2CA PPP2CB	7.53e-04	25	37	2	CID000133020
Drug	5-nitrosalicylaldehyde	DPP4 DPP9	7.53e-04	25	37	2	CID000066808
Drug	manganese chloride	DPP4 CELSR1 MYOM1 HEPH INSR	8.10e-04	456	37	5	ctd:C025340
Drug	B-Ms	DPP4 EFS NOTCH2	8.39e-04	114	37	3	CID000445091
Drug	Arg-pro-pro	DPP4 DPP9	8.79e-04	27	37	2	CID000152660
Drug	Deprolorphin	DPP4 DPP9	9.46e-04	28	37	2	CID000122318
Drug	ValboroPro	DPP4 DPP9	9.46e-04	28	37	2	CID006918572
Drug	protocatechuic acid	DPP4 DPP9 ALOX15B	9.50e-04	119	37	3	CID000000072
Disease	seminoma (is_marker_for)	JUP INSR	3.67e-04	22	38	2	DOID:4440 (is_marker_for)
Disease	Drug habituation	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0013170
Disease	Substance-Related Disorders	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0236969
Disease	Drug abuse	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0013146
Disease	Drug Use Disorders	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0013222
Disease	Drug Dependence	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C1510472
Disease	Substance Dependence	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0038580
Disease	Substance Use Disorders	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0038586
Disease	Organic Mental Disorders, Substance-Induced	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C0029231
Disease	Prescription Drug Abuse	PCDH15 CHD1L INSR	4.40e-04	115	38	3	C4316881
Disease	Substance abuse problem	PCDH15 CHD1L INSR	4.52e-04	116	38	3	C0740858
Disease	diabetes mellitus (implicated_via_orthology)	LRP1 INSR	5.15e-04	26	38	2	DOID:9351 (implicated_via_orthology)
Disease	presubiculum volume	DPP4 WNK2	7.33e-04	31	38	2	EFO_0009400
Disease	hippocampus molecular layer volume	DPP4 WNK2	9.35e-04	35	38	2	EFO_0009397
Disease	dentate gyrus volume measurement	DPP4 ALOX15B	1.16e-03	39	38	2	EFO_0010083

Protein segments in the cluster

Peptide	Gene	Start	Entry
MYDDSYVPGFEDSEA	CACNB3	1	P54284
ADSYYYEDGGMKPRV	CCDC50	141	Q8IVM0
DYGDGYVIPNYDDMD	AEBP1	301	Q8IUX7
MDPEETSVYLDYYYA	GPR15	1	P49685
NPEEMTSRDYYFDSY	PRMT8	66	Q9NR22
YTIEGEEERVSYYME	CELSR1	271	Q9NYQ6
YVYVFDGYRMEECAP	ANO2	656	Q9NQ90
RGDRYMLVTYDEPPY	INTS6L	46	Q5JSJ4
QYPYDRYGTMDSGTR	IRX4	131	P78413
IEDSGYKEYYSIPVM	ANKAR	416	Q7Z5J8
RDSQGELMVYPYYGE	NOTCH2	1581	Q04721
YYIEYMESTRDDSPL	JMJD6	116	Q6NYC1
PYDVQYSDIDYMDGK	MGAM2	361	Q2M2H8
MSYPADDYESEAAYD	EIF3L	1	Q9Y262
MEIRGVDLDAPYYNY	LRP1	1591	Q07954
SYPYSEDARQGEQYM	INPP5A	326	Q14642
DESEMLGSTPYTYYG	LHX5	266	Q9H2C1
YYDSVYTERYMGLPT	DPP4	661	P27487
YHLERYPDSYESMSE	TUBGCP6	1426	Q96RT7
GDFGMTRDIYETDYY	INSR	1176	P06213
LFMGDYVDRGYYSVE	PPP2CB	81	P62714
LFMGDYVDRGYYSVE	PPP2CA	81	P67775
EPYGDDMDATYRPMY	JUP	691	P14923
YMYAPEDAEVLRPYS	SBF1	1571	O95248
EISYDVYVYTDMRPG	PCDH15	511	Q96QU1
AYDTGYTERYMDVPE	DPP9	761	Q86TI2
DRGDGMYKVEYTPYE	FLNA	1311	P21333
DYMDYRGYSYERVDG	CHD1L	381	Q86WJ1
EYEGIPMAEEYDYVH	EFS	371	O43281
YEDMIGEEVPSDQYY	CTNND1	321	O60716
RPYAYMYNSDKDTVE	KIF1A	1601	Q12756
EDIPGYYYRDDGMQI	ALOX15B	466	O15296
SEEAYIDPIAMEYYN	LAT2	106	Q9GZY6
IYYSAVDPIKDMYSG	HEPH	881	Q9BQS7
VIVMEYASRGDLYDY	NUAK2	126	Q9H093
VPYASENAIYEMGYT	LINC00643	21	Q86TS7
PEMYEEHYDESVDVY	WNK2	366	Q9Y3S1
DEGLYTIRVRMGEYY	MYOM1	476	P52179
SYYQPDMEYSEIVGL	PPP1R9A	431	Q9ULJ8